Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Diabetic Foot Australia (DFA) is a national clinical and research initiative dedicated to ending avoidable amputations caused by diabetes-related foot disease. The organization develops and implements evidence-based clinical guidelines, coordinates national research efforts, and provides educational resources for healthcare professionals. DFA operates as a collaborative body under the Australian Diabetes Society, partnering with various clinical groups to improve patient outcomes across Australia. Their work primarily focuses on wound management, offloading techniques, and establishing multidisciplinary care pathways for diabetic foot ulcers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Diabetic Foot Australia.